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Original Article
Evaluation of predominant Neisseria gonorrhoeae strain types and its
correlation with fluoroquinolone resistance in Pakistan
Summiya Nizamuddin, Kauser Jabeen, Afia Zafar
Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi.

Abstract
Objective: To study the predominant Neisseria gonorrhoeae strain types in Pakistan and to evaluate their
correlation with fluoroquinolone resistance.
Method: A total of 314 strains were collected from 2007-2009. Of these 112 strains were randomly selected for
serotyping via the coagglutination technique. Fluoroquinolone susceptibility was checked through the E-test
method. Chi square was performed to assess the correlation between the strain type and fluoroquinolone
resistance pattern.
Results: N. gonorrhoeae isolates were typed in two serogroups and 28 serovars. Serogroup WI comprised 40%
(n=45) whereas WII/WIII was 60% (n=67). Most commonly isolated serovar belonged to serogroup WI namely
Aorst (10%). The other predominant circulating serovars of the serogroup WI were Aost (9%) and Ast (8%) and
Bsy (8%), Bopyt (5%) and Bprt (4.5%) in the serogroup WII/III. Fluoroquinolone resistance was 98%, with an MIC
of 2µg/mL in 47%, 4µg/mL in 36% and >32µg/mL in 12% of the isolates. On inferential analysis no significant
correlation was observed between fluoroquinolone resistance and any particular serovars.
Conclusion: A diverse population of N. gonorrhoeae serovars suggesting influx of a variety of gonococcal
strains with high fluoroquinolone resistance was identified. This resistance was not associated with any particular
serovars, so we speculated inappropriate use of fluoroquinolones in the community to be a major cause.
Injudicious fluoroquinolone use in the community should be strongly discouraged to curtail increase in
antimicrobial resistance. Furthermore, continuous surveillance of prevalent serovars will be critical to assess
genetic alterations of endemic and imported strains to design effective disease control measures.
Keywords: Neisseria gonorrhea, Fluoroquinolone resistance, Serotyping, Pakistan (JPMA 61:446; 2011).

Introduction
Global spread of Neisseria gonorrhoeae represents a
major concern due to extremely limited treatment options.1
This increase has been associated with either unregulated use
of fluoroquinolones leading to selective pressure or due to
importation of cases from areas with high incidence of
quinolone resistance.2 Continuous monitoring of resistance
pattern is crucial for appropriate management of cases as
resistance could vary in different regions and over different
time periods.3 In a community, resistance to a particular drug
is usually driven by prevalent strain types and thus
characterization of these isolates is required to identify their
routes of dissemination and application of possible
preventive and treatment strategies.4 Published data has
shown a strong correlation between fluoroquinolone
resistance and certain N. gonorrhoeae serovars suggesting
accumulation and propagation of these strains in their
settings.2,5
Actual burden of gonococcal infections in Pakistan is
not known, however these infections are common, especially
in high risk populations, leading to a high cost of treatment of
both primary and complicated cases.6,7 High resistance rates
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to fluoroquinolone have been previously reported from the
country in 2005 and 2007.3,8 Given the scale of public health
importance of gonorrhea, with the widespread use of
fluoroquinolone as an empirical agent, surveillance for drug
resistance is crucial at the local level. Previous data of
prevalent serovars of N. gonorrhoeae is currently lacking
from Pakistan, hence information regarding strains prevalent
in the community and their association with resistance would
essentially be required to target disease prevention.
In this study we determined serovar distribution of
gonococcal isolates (2007-2009) by employing co-agglutination
technique. Furthermore an association was determined between
fluoroquinolone resistance and strain types.

Materials and Methods
This study was conducted in the clinical microbiology
laboratory of a tertiary care hospital in Karachi, Pakistan. The
laboratory has a well established national specimen collection
network and it receives specimens collected through the
peripheral units, located in major cities and towns across the
country. Specimens were requested by physicians and were then
submitted at collection units. They were transported in a
controlled environment to main laboratory within 24 hours. The
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laboratory data presented in this study, though not collected
through a programmed survey, is representative of the country.
Collection of isolates: N. gonorrhoeae strains isolated
between the years 2007 and 2009 were included in the study.
Laboratory methods: During the study period, N.
gonorrhoeae was isolated and identified using standard
microbiological procedure.9 All isolates were then saved in
glycerol phosphate broth and stored at -80°C.

Antimicrobial susceptibility testing:
Antimicrobial susceptibility testing was performed
using the disk diffusion method according to Clinical
Laboratory Standards Institute (CLSI).10 Minimum inhibitory
concentration (MIC) of ofloxacin was determined for all
isolates via the E-test method as specified by the
manufacturer (AB biodisk, Sweden). N. gonorrhoeae ATCC
49226 was used as control for disc diffusion and MIC testing.

Table: Distribution of Neisseria gonorrhoeae strains
into serogroups and serovars (n = 112).

Serotyping:
Selected isolates were revived from the strain bank
and were serotyped using the co-agglutination technique.11
Serotyping was performed using the Phadebact GC serovar
kit (Boule Diagnostic AB, Sweden) which consisted of five
reagents for WI serogroup (Ao, Ar, As, At and Av) and nine
reagents for WII/WIII serogroup (Bo, Bp, Br, Bs, Bt, Bu, Bv,
Bx, and By). All serovars were classified into serogroups WI
and WII/WIII and further sub divided into serovars.
Epidemiological data for gonococcal isolates was
entered into computer software Epidata; and transferred to
SPSS software for statistical analysis. In descriptive
percentage of the categorical variables (antibiotic resistance)
was computed. In inferential analysis chi square was run to
assess the correlation between the strain type and
fluoroquinolone resistance pattern.

Results
During the study period a total of 314 N. gonorrhoeae
were isolated. Of these 112 strains were randomly selected
and serotyped. Fluoroquinolone resistance was seen in 98%
of these isolates.
The distribution of isolates according to their
susceptibilities to ofloxacin is depicted in Figure. According
to CLSI breakpoints 3 of the isolates were susceptible to
ofloxacin (MICs, < 0.25µg/mL), 4 were intermediate (MICs,
0.5 - 1µg/mL) and a total of 105 isolates were found to be
resistant to ofloxacin (MICs, > 2µg/mL). Out of these 105
isolates, 47% (n=52) had MIC 2µg/mL, 36% (n=40) had
4µg/mL and 12% (n=13) had >32 µg/mL. MIC50 was 2
µg/ml and MIC90 was >32 µg/ml.
Majority (60%) of strains belonged to serogroup
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Figure: Distribution of N. gonorrhoeae isolates (n= 112) according
to ofloxacin MICs (µgml).

Serogroup

Serovar

No. (%)

WI (n=45)

Aorst
Aost
Ast
Arst
At
Aostv
Ars
Bsy
Bopyt
Brpt
Bropt
Bopsty
Bst
Bpt
Bo
Bpyvut
Bpty
Brpyst
Bpr
Bosty
Bsty
Bropyst
Boprst
Bpyvut
Bropyt
Btuvy
Bptuvx
Bopsy
Borty
Bost
Brop
Btvy
Bosy
Bpsty
Bprty

11 (10)
10 (9)
9 (8)
7 (6)
6 (5)
1 (0.9)
1 (0.9)
9 (8)
6 (5)
5 (4.5)
4 (3.6)
4 (3.6)
4 (3.6)
4 (3.6)
3 (2.7)
2 (1.8)
2 (1.8)
2 (1.8)
2 (1.8)
2 (1.8)
2 (1.8)
2 (1.8)
2(1.8)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)
1 (0.9)

WII/WIII (n=67)

WII/WIII (IB) followed by serogroup WI (IA) (40%) (Table).
Most commonly isolated serovar belonged to the serogroup
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WI namely Aorst (10%). The other predominant circulating
serovars of the serogroup WI were Aost (9%) and Ast (8%)
and Bsy (8%), Bopyt (5%) and Brpt (4.5%) in the serogroup
WII/III (Table).
In inferential analysis, no significant association was
observed between strain types and fluoroquinolone resistance
(p = 0.481).

Discussion
The results of this study demonstrated a wide variety of
serovar distribution and very high fluoroquinolone resistance
rate amongst N. gonorrhoeae isolated from Pakistan.
Most of the local strains (60%) belonged to WII/WIII
serogroup, which is consistent with data reported from India,
Turkey and Singapore.12-14 Seven serovars were grouped as
WI whereas twenty eight serovars belonging to the serogroup
WII/III were identified. The most prevalent serovar overall
was Aorst (10%), followed by Aost (9%) and then Ast (8%)
and Bsy (8%). Data from India also demonstrated similar
predominant serovars Aost and Aorst in WI serogroup. In
contrast common serovars from WII/WIII serogroup were
Boprt and Btuvy in their study.13 Similar studies reported
Bropyst and Bpyvut from Greece and Bsty from Turkey as
their common serovars.13,14
Our results clearly show diversity in circulating N.
gonorrhoeae strains and no single predominant serovar was
identified in these strains. Karachi, the origin of most of the
specimens, is a cosmopolitan city with a multi ethnic
background and so, importation of strains from areas both within
and outside the country might be the reason for this finding.
This study also highlighted a dramatic increase in
fluoroquinolone resistance from 42% to 98% in the last seven
years. This reflects consistent overuse of this drug despite the
presence of fluoroquinolone resistance in the community. In
Pakistan, antibiotics are available as over the counter
medications and fluoroquinolones are commonly used as a
treatment option in gonococcal and other infections due to its
comparatively low cost and oral administration.
In this study no significant association was found
between fluoroquinolone resistance and strain types. In
contrast, a recent study from Greece has shown a significant
association between the serovar Bropyst and fluoroquinolone
resistance.13 They had correlated this finding to clonal
selection and spread of these resistant strains as the cause of
increased prevalence of fluoroquinolone resistance.
Unfortunately, we were not able to show this association
probably due to prevalence of multiple serovars or may be
due to the low number of isolates in individual serovars.
The major limitation of this study was its small sample
size. This could be the factor responsible for poor correlation
Vol. 61, No. 5, May 2011

between strain typing and drug resistance as very low number
of isolates were found in individual serovars. Secondly, since
we do not have any prior serotyping data of N. gonorrhoeae
from Pakistan, we were not able to assess any change in their
pattern along with the marked increase in resistance pattern to
fluoroquinolones. Thirdly the method used for strain typing
was not adequate for the accurate analysis of N. gonorrhoeae
isolates; however in a resource limited country analysis of
serovars using conventional methods could be used as an early
tool to identify any change or shift in a clinical laboratory.
In conclusion we identified a diverse population of N.
gonorrhoeae serovars in local isolates suggesting influx of a
variety of gonococcal strains. High resistance to
fluoroquinolones was observed but we had not been able to
link this with any particular serovar. We relate high resistance
to inappropriate and indiscriminate use of this drug in the
community mandating implementation of antibiotic restriction
policies and judicious use by physicians. Knowledge of
currently existing serovars to identify clonal spread of
resistance strains and continuous monitoring of serovars will
be required, as temporal changes may demonstrate genetic
alterations of existing strains and the importation of strains
from different geographical regions. This information could
then be utilized to design effective disease control measures
and to curtail increase in antimicrobial resistance.
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